Robert S. Wehbie

903 total citations
17 papers, 707 citations indexed

About

Robert S. Wehbie is a scholar working on Infectious Diseases, Molecular Biology and Cell Biology. According to data from OpenAlex, Robert S. Wehbie has authored 17 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Robert S. Wehbie's work include Aldose Reductase and Taurine (4 papers), HIV/AIDS drug development and treatment (3 papers) and Selenium in Biological Systems (2 papers). Robert S. Wehbie is often cited by papers focused on Aldose Reductase and Taurine (4 papers), HIV/AIDS drug development and treatment (3 papers) and Selenium in Biological Systems (2 papers). Robert S. Wehbie collaborates with scholars based in United States, Israel and Russia. Robert S. Wehbie's co-authors include Steve C. Pettit, Christine A. Klein, Pascale V. Nantermet, M. D. Moody, Henry A. Lardy, John W. Erickson, Sabah Sallah, Mark F. Knigge, Haim Breitbart and Lorraine Everitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Robert S. Wehbie

17 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Wehbie United States 11 428 399 173 163 112 17 707
Octavian Schatz Germany 12 672 1.6× 741 1.9× 148 0.9× 733 4.5× 77 0.7× 14 1.1k
Zenda Woodman South Africa 16 193 0.5× 273 0.7× 93 0.5× 205 1.3× 77 0.7× 26 600
Amanda E. Jetzt United States 12 342 0.8× 451 1.1× 126 0.7× 325 2.0× 32 0.3× 20 774
Ryan B. Turner United States 14 203 0.5× 323 0.8× 134 0.8× 494 3.0× 95 0.8× 19 823
LEOTA HALL United States 7 229 0.5× 398 1.0× 142 0.8× 139 0.9× 94 0.8× 8 596
D Bergeron Canada 15 131 0.3× 177 0.4× 114 0.7× 513 3.1× 52 0.5× 25 1.1k
C.-Y. Ou United States 10 198 0.5× 229 0.6× 104 0.6× 325 2.0× 50 0.4× 12 708
A. Mohsin Mian United States 15 472 1.1× 363 0.9× 169 1.0× 421 2.6× 141 1.3× 34 941
John Abbotts United States 14 581 1.4× 576 1.4× 88 0.5× 793 4.9× 40 0.4× 33 1.2k
J S Culp United States 11 420 1.0× 510 1.3× 136 0.8× 443 2.7× 43 0.4× 11 918

Countries citing papers authored by Robert S. Wehbie

Since Specialization
Citations

This map shows the geographic impact of Robert S. Wehbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Wehbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Wehbie more than expected).

Fields of papers citing papers by Robert S. Wehbie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Wehbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Wehbie. The network helps show where Robert S. Wehbie may publish in the future.

Co-authorship network of co-authors of Robert S. Wehbie

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Wehbie. A scholar is included among the top collaborators of Robert S. Wehbie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Wehbie. Robert S. Wehbie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wehbie, Robert S., et al.. (2022). Endogenous carbon monoxide due to hemolytic anemia: A forensic red herring. Journal of Forensic Sciences. 67(3). 1294–1299. 1 indexed citations
2.
Wehbie, Robert S., et al.. (2015). The Feasibility of a Telemedicine Platform to Monitor Adherence and Adverse Effects of ABL Kinase Inhibitors. Blood. 126(23). 3308–3308. 2 indexed citations
3.
Quinlivan, E. Byrd, Chuan Zhang, Paul W. Stewart, et al.. (2002). Elevated Virus Loads of Kaposi’s Sarcoma–Associated Human Herpesvirus 8 Predict Kaposi's Sarcoma Disease Progression, but Elevated Levels of Human Immunodeficiency Virus Type 1 Do Not. The Journal of Infectious Diseases. 185(12). 1736–1744. 64 indexed citations
4.
Sallah, Sabah, et al.. (1999). Hepatosplenic candidiasis in patients with acute leukaemia. British Journal of Haematology. 106(3). 697–701. 56 indexed citations
5.
Sallah, Sabah, et al.. (1999). The role of 2‐chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. British Journal of Haematology. 104(1). 163–165. 21 indexed citations
6.
Pettit, Steve C., et al.. (1998). HIV Type 1 Protease Inhibitors Fail to Inhibit HTLV-I Gag Processing in Infected Cells. AIDS Research and Human Retroviruses. 14(11). 1007–1014. 20 indexed citations
7.
Dehmer, Gregory, et al.. (1997). Absence of Human Herpesvirus 8 Genomes in Coronary Atherosclerosis in Immunocompetent Patients. The American Journal of Cardiology. 79(9). 1245–1247. 6 indexed citations
8.
Kassel, Daniel B., et al.. (1995). HIV-1 Protease Specificity Derived from a Complex Mixture of Synthetic Substrates. Analytical Biochemistry. 228(2). 259–266. 10 indexed citations
9.
Kaplan, Andrew H., Robert S. Wehbie, Mark F. Knigge, et al.. (1994). Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.. Proceedings of the National Academy of Sciences. 91(12). 5597–5601. 139 indexed citations
10.
11.
Breitbart, Haim, Robert S. Wehbie, & Henry A. Lardy. (1990). Calcium transport in bovine sperm mitochondria: effect of substrates and phosphate. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1026(1). 57–63. 16 indexed citations
12.
Breitbart, Haim, Robert S. Wehbie, Jovenal San Agustin, & Henry A. Lardy. (1990). Inhibition by caltrin of calcium transport into spermatozoa, liver and heart mitochondria. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1022(1). 27–32. 5 indexed citations
13.
Breitbart, Haim, Robert S. Wehbie, & Henry A. Lardy. (1990). Regulation of calcium transport in bovine spermatozoa. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1027(1). 72–78. 22 indexed citations
14.
Wehbie, Robert S., Narayan S. Punekar, & Henry A. Lardy. (1988). Rat liver .gamma.-butyrobetaine hydroxylase catalyzed reaction: influence of potassium, substrates, and substrate analogs on hydroxylation and decarboxylation. Biochemistry. 27(6). 2222–2228. 23 indexed citations
15.
Punekar, Narayan S., Robert S. Wehbie, & H A Lardy. (1987). gamma-Butyrobetaine hydroxylase and the protective role of glutathione peroxidase.. Journal of Biological Chemistry. 262(14). 6720–6724. 8 indexed citations
16.
Wehbie, Robert S., et al.. (1987). The antibiotic W341C, its ion transport properties and inhibitory effects on mitochondrial substrate oxidation.. The Journal of Antibiotics. 40(6). 887–893. 5 indexed citations
17.
Wehbie, Robert S., et al.. (1986). The role of malate in hormone-induced enhancement of mitochondrial respiration. Archives of Biochemistry and Biophysics. 245(2). 477–482. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026